Prokidney (PROK) Shares Outstanding (2021 - 2026)

Prokidney (PROK) has reported Shares Outstanding (Entity) for 6 consecutive years, with $511.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 19.53% year-over-year to $511.2 million in Q2 2026; TTM through Jun 2026 was $511.2 million, a 19.53% increase from a year earlier, with the FY2025 full-year figure at $442.9 million, up 5.5% from the prior year.
• Shares Outstanding (Entity) was $511.2 million for Q2 2026 at Prokidney, up from $443.9 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $511.2 million in Q2 2026 and troughed at $25.6 million in Q1 2022.
• A 5-year average of $336.1 million and a median of $356.3 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The widest YoY moves for Shares Outstanding (Entity): up 1306.18% in 2022, down 19.79% in 2022.
• Over 5 years, Shares Outstanding (Entity) stood at $294.7 million in 2022, then declined by 2.24% to $288.1 million in 2023, then jumped by 45.74% to $419.8 million in 2024, then climbed by 5.5% to $442.9 million in 2025, then climbed by 15.44% to $511.2 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $511.2 million (Q2 2026), $443.9 million (Q1 2026), and $442.9 million (Q4 2025), per Business Quant data.